Major molecular response achieved with dasatinib in a CML patient with F317L BCR-ABL kinase domain mutation
Gespeichert in:
| Veröffentlicht in: | Leukemia research 2010, Vol.34 (4), p.e91-e93 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Report |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e93 |
|---|---|
| container_issue | 4 |
| container_start_page | e91 |
| container_title | Leukemia research |
| container_volume | 34 |
| creator | Faber, Edgar Mojzikova, Renata Plachy, Radek Rozmanova, Sarka Stastny, Marek Divoka, Martina Jarosova, Marie Indrak, Karel Divoky, Vladimir |
| description | |
| doi_str_mv | 10.1016/j.leukres.2009.09.009 |
| format | Report |
| fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_733811695</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733811695</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_7338116953</originalsourceid><addsrcrecordid>eNqNjE9LxDAUxIMguP75CMK7eWpNDN02R7e4eOhexPvybJ9s2jSpfYl-fSP6AYSBgZnfjBC3SpZKqu39WDpK00pcPkhpyh9JcyY2qql1UTW6uhCXzKOUsjLKbMR0wDGsMAdHfXK4Qp4uwTMB9idLnzTAl40nGJAxWm_fwHpAaA8dLDkgH3_7vVZ1B7v2pXjcdTBZj_liCDNmfE4xo8Ffi_N3dEw3f34l7vZPr-1zsazhIxHH42y5J-fQU0h8rLVulNqaSv-f_Aa-v1HW</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>report</recordtype><pqid>733811695</pqid></control><display><type>report</type><title>Major molecular response achieved with dasatinib in a CML patient with F317L BCR-ABL kinase domain mutation</title><source>Elsevier ScienceDirect Journals</source><creator>Faber, Edgar ; Mojzikova, Renata ; Plachy, Radek ; Rozmanova, Sarka ; Stastny, Marek ; Divoka, Martina ; Jarosova, Marie ; Indrak, Karel ; Divoky, Vladimir</creator><creatorcontrib>Faber, Edgar ; Mojzikova, Renata ; Plachy, Radek ; Rozmanova, Sarka ; Stastny, Marek ; Divoka, Martina ; Jarosova, Marie ; Indrak, Karel ; Divoky, Vladimir</creatorcontrib><identifier>EISSN: 1873-5835</identifier><identifier>DOI: 10.1016/j.leukres.2009.09.009</identifier><language>eng</language><ispartof>Leukemia research, 2010, Vol.34 (4), p.e91-e93</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>777,781,4476,27906</link.rule.ids></links><search><creatorcontrib>Faber, Edgar</creatorcontrib><creatorcontrib>Mojzikova, Renata</creatorcontrib><creatorcontrib>Plachy, Radek</creatorcontrib><creatorcontrib>Rozmanova, Sarka</creatorcontrib><creatorcontrib>Stastny, Marek</creatorcontrib><creatorcontrib>Divoka, Martina</creatorcontrib><creatorcontrib>Jarosova, Marie</creatorcontrib><creatorcontrib>Indrak, Karel</creatorcontrib><creatorcontrib>Divoky, Vladimir</creatorcontrib><title>Major molecular response achieved with dasatinib in a CML patient with F317L BCR-ABL kinase domain mutation</title><title>Leukemia research</title><issn>1873-5835</issn><fulltext>true</fulltext><rsrctype>report</rsrctype><creationdate>2010</creationdate><recordtype>report</recordtype><recordid>eNqNjE9LxDAUxIMguP75CMK7eWpNDN02R7e4eOhexPvybJ9s2jSpfYl-fSP6AYSBgZnfjBC3SpZKqu39WDpK00pcPkhpyh9JcyY2qql1UTW6uhCXzKOUsjLKbMR0wDGsMAdHfXK4Qp4uwTMB9idLnzTAl40nGJAxWm_fwHpAaA8dLDkgH3_7vVZ1B7v2pXjcdTBZj_liCDNmfE4xo8Ffi_N3dEw3f34l7vZPr-1zsazhIxHH42y5J-fQU0h8rLVulNqaSv-f_Aa-v1HW</recordid><startdate>20100401</startdate><enddate>20100401</enddate><creator>Faber, Edgar</creator><creator>Mojzikova, Renata</creator><creator>Plachy, Radek</creator><creator>Rozmanova, Sarka</creator><creator>Stastny, Marek</creator><creator>Divoka, Martina</creator><creator>Jarosova, Marie</creator><creator>Indrak, Karel</creator><creator>Divoky, Vladimir</creator><scope>7X8</scope></search><sort><creationdate>20100401</creationdate><title>Major molecular response achieved with dasatinib in a CML patient with F317L BCR-ABL kinase domain mutation</title><author>Faber, Edgar ; Mojzikova, Renata ; Plachy, Radek ; Rozmanova, Sarka ; Stastny, Marek ; Divoka, Martina ; Jarosova, Marie ; Indrak, Karel ; Divoky, Vladimir</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_7338116953</frbrgroupid><rsrctype>reports</rsrctype><prefilter>reports</prefilter><language>eng</language><creationdate>2010</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Faber, Edgar</creatorcontrib><creatorcontrib>Mojzikova, Renata</creatorcontrib><creatorcontrib>Plachy, Radek</creatorcontrib><creatorcontrib>Rozmanova, Sarka</creatorcontrib><creatorcontrib>Stastny, Marek</creatorcontrib><creatorcontrib>Divoka, Martina</creatorcontrib><creatorcontrib>Jarosova, Marie</creatorcontrib><creatorcontrib>Indrak, Karel</creatorcontrib><creatorcontrib>Divoky, Vladimir</creatorcontrib><collection>MEDLINE - Academic</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Faber, Edgar</au><au>Mojzikova, Renata</au><au>Plachy, Radek</au><au>Rozmanova, Sarka</au><au>Stastny, Marek</au><au>Divoka, Martina</au><au>Jarosova, Marie</au><au>Indrak, Karel</au><au>Divoky, Vladimir</au><format>book</format><genre>unknown</genre><ristype>RPRT</ristype><atitle>Major molecular response achieved with dasatinib in a CML patient with F317L BCR-ABL kinase domain mutation</atitle><jtitle>Leukemia research</jtitle><date>2010-04-01</date><risdate>2010</risdate><volume>34</volume><issue>4</issue><spage>e91</spage><epage>e93</epage><pages>e91-e93</pages><eissn>1873-5835</eissn><doi>10.1016/j.leukres.2009.09.009</doi></addata></record> |
| fulltext | fulltext |
| identifier | EISSN: 1873-5835 |
| ispartof | Leukemia research, 2010, Vol.34 (4), p.e91-e93 |
| issn | 1873-5835 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_733811695 |
| source | Elsevier ScienceDirect Journals |
| title | Major molecular response achieved with dasatinib in a CML patient with F317L BCR-ABL kinase domain mutation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T06%3A29%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.atitle=Major%20molecular%20response%20achieved%20with%20dasatinib%20in%20a%20CML%20patient%20with%20F317L%20BCR-ABL%20kinase%20domain%20mutation&rft.jtitle=Leukemia%20research&rft.au=Faber,%20Edgar&rft.date=2010-04-01&rft.volume=34&rft.issue=4&rft.spage=e91&rft.epage=e93&rft.pages=e91-e93&rft.eissn=1873-5835&rft_id=info:doi/10.1016/j.leukres.2009.09.009&rft_dat=%3Cproquest%3E733811695%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733811695&rft_id=info:pmid/&rfr_iscdi=true |